PDF 99 kB
Tjoapack receives investment from Ampersand Capital Partners
We're delighted to announce today that Tjoapack has received a majority investment from Ampersand Capital Partners, a private equity firm specialising in the pharmaceutical and healthcare industry. The investment will allow us to continue to expand our capabilities and capacity to meet rising customer demand, as well as help support us in achieving our long-term strategic growth.
In addition to the investment, Dexter Tjoa, our Director Corporate Strategy, has been appointed as the new CEO taking over from our founder, Eric Tjoa. Eric will maintain a seat on the Board alongside our new investors.
Read more about the investment here